Skip to
  1. Homepage
  2. Rare diseases
  3. Search
Simple search

Simple search

*
(*) mandatory field





 

Other search option(s)

Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency

ORPHA70592
Synonym(s) IRAK4 deficiency
Prevalence <1 / 1 000 000
Inheritance Autosomal recessive
Age of onset Childhood
ICD-10
  • D84.8
OMIM
UMLS -
MeSH -
MedDRA -

Summary

Interleukin-1 receptor-associated kinase-4 (IRAK-4) deficiency is an immunodeficiency associated with increased susceptibility to invasive infections caused by pyogenic bacteria. It has been described in less than 15 patients from eight families with onset occurring during childhood. The most common recurrent infections in these patients were caused by Streptococcus pneumoniae or Staphylococcus aureus, leading to a range of clinical manifestations such as pneumonia, septic arthritis, cellulitis, osteomyelitis, otitis media, meningitis and sinusitis. In contrast, the patients appeared to be resistant to infection caused by most other bacteria, parasites and viruses but fungal infections have been reported. Although routine immunological evaluations generally gave normal results, the patients displayed reduced inflammatory responses and neutropenia during infectious episodes. IRAK-4 deficiency is caused by mutations in the IRAK-4 gene (chromosome 12q12). IRAK-4 is a member of the IRAK protein kinase family and is involved in the toll-interleukin 1 (TIR) signalling pathway. IRAK-4 deficiency should be suspected in patients with a failure to sustain antibody responses and recurrent pyogenic bacterial infections. Diagnosis can be confirmed by detection of IRAK-4 gene mutations and through characterisation of the reduced response of blood cells and fibroblasts to stimulation with a large range of interleukin-1 receptor (IL-1R) and toll-like receptor (TLR) ligands and whole bacteria (S. aureus, Escherichia coli and Mycobacterium tuberculosis). Intravenous immunoglobulin therapy (IVIG), antibiotic prophylaxis and administration of the heptavalent pneumococcal-conjugated vaccine have provided successful results in some cases. The prognosis for most patients is good, with infections becoming less frequent with age. However, bacterial meningitis has lead to death in a few cases, particularly when it occurred during infancy.

Expert reviewer(s)

  • Pr Alain FISCHER

(*) Required fields.

Attention: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed.


Captcha image
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.